|
Survival of subjects with recurrent glioblastoma receiving intratumoral administration of controlled IL-12 with limited exposure to dexamethasone. |
|
|
Consulting or Advisory Role - Abbvie; Eisai; Monteris Medical |
Speakers' Bureau - Novocure |
Research Funding - Bristol-Myers Squibb |
Expert Testimony - Loyola University Medical Center |
Travel, Accommodations, Expenses - Novocure |
Other Relationship - American Physician Institute; EBSCO; MedLink Neurology |
|
|
Other Relationship - Advanced Accelerator Applications; Bristol-Myers Squibb |
|
|
No Relationships to Disclose |
|
|
Research Funding - Bristol-Myers Squibb (Inst); Orbus Therapeutics (Inst); ZIOPHARM Oncology (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Employment - ZIOPHARM Oncology |
Stock and Other Ownership Interests - ZIOPHARM Oncology |
Travel, Accommodations, Expenses - ZIOPHARM Oncology |
|
|
Employment - Epizyme; ZIOPHARM Oncology |
Stock and Other Ownership Interests - ZIOPHARM Oncology |
Patents, Royalties, Other Intellectual Property - IL-12 |
Travel, Accommodations, Expenses - ZIOPHARM Oncology |
|
|
Employment - Kiniksa; ZIOPHARM Oncology |
|
|
Employment - ZIOPHARM Oncology |
Travel, Accommodations, Expenses - ZIOPHARM Oncology |
|
|
Employment - ZIOPHARM Oncology |
Stock and Other Ownership Interests - ZIOPHARM Oncology |
|
|
Employment - ZIOPHARM Oncology |
Stock and Other Ownership Interests - ZIOPHARM Oncology |
|
|
No Relationships to Disclose |
|
|
Employment - ZIOPHARM Oncology |
Stock and Other Ownership Interests - Merck; Quest Diagnostics; ZIOPHARM Oncology |
Research Funding - ZIOPHARM Oncology |
Patents, Royalties, Other Intellectual Property - Ziopharm Oncology (Inst) |
|
|
Employment - ZIOPHARM Oncology |
Leadership - ZIOPHARM Oncology |
Stock and Other Ownership Interests - cellchorus; CytoSen; Immatics; Secure Transfusion Services; Taro; ZIOPHARM Oncology |
Patents, Royalties, Other Intellectual Property - City of Hope; Immatics; MD Anderson Cancer Center; Sangamo Bioscience; ZIOPHARM Oncology |